Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Albert Schweitzer Hospital | OTHER |
| Canisius-Wilhelmina Hospital | OTHER |
| Diakonessenhuis, Utrecht | OTHER |
| Erasmus Medical Center |
Not provided
Not provided
Not provided
Not provided
Rationale:To improve the definition of the target volume for radiotherapy of the chestwall after different types of mastectomy, the exact localization of regions at risk for a local recurrence should be known. However, there are currently insufficient data in literature showing where local recurrences occur after different types of mastectomy.
Objective: The primary objective of the proposed study is to determine whether the spatial, location of a breast cancer recurrence after mastectomy, differs for different types of mastectomy.
Study design: Retrospective study evaluating spatial location and site of recurrences after mastectomy.
Study population: The investigators aim to include all breast cancer patients treated with mastectomy in the Netherlands between 2003- 2008, and known to have experienced a local recurrence as the first site of failure.
Primary endpoint: Spatial location of local recurrence (e.g., primary tumour bed, scar, skin, subcutaneous, nipple, areola, pectoral muscles).
Rationale:To improve the definition of the target volume for radiotherapy of the chestwall after different types of mastectomy, the exact localization of regions at risk for a local recurrence should be known. However, there are currently insufficient data in literature showing where local recurrences occur after different types of mastectomy.
Objective: The primary objective of the proposed study is to determine whether the spatial, location of a breast cancer recurrence after mastectomy, differs for different types of mastectomy. Secondary objectives are to assess whether tumour characteristics (e.g., molecular subtypes, lymphangio/lymphovascular invasion) and treatment-related factors (e.g., PMRTwith or without bolus, radiation volumes, doses) influence the site of recurrence and spatial location.
Study design: Retrospective study evaluating spatial location and site of recurrences after mastectomy.
Study population: The investigators aim to include all breast cancer patients treated with mastectomy in the Netherlands between 2003- 2008, and known to have experienced a local recurrence as the first site of failure.
Primary endpoint: Primary endpoint: Spatial location of local recurrence (e.g., primary tumour bed, scar, skin, subcutaneous, nipple, areola, pectoral muscles).
Other study parameters: First descriptive statistics will be performed to investigate whether there is a relation between the localization of the recurrence and the type of mastectomy: modified radical mastectomy (MRM), skin-sparing mastectomy (SSM), nipple sparing mastectomy (NSM).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mastectomy | Procedure | Mastectomy as a surgical procedure for breast cancer (regardless of perioperative treatment). |
| Measure | Description | Time Frame |
|---|---|---|
| Spatial localisation of local recurrences | The primary objective of the proposed study is to determine whether the spatial, location of a breast cancer recurrence after mastectomy, differs for different types of mastectomy. | Up to 15 years after mastectomy |
| Measure | Description | Time Frame |
|---|---|---|
| Influence of tumour characteristics on the site of recurrence and spatial location. | Anaysis to assess whether tumour characteristics (e.g., molecular subtypes, lymphangio/lymphovascular invasion) influence the site of recurrence and spatial location. | Up to 15 years after mastectomy |
| Influence of treatment-related factors on the site of recurrence and spatial location. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
We aim to include all breast cancer patients treated with mastectomy in the Netherlands between 2003- 2008, and known to have experienced a local or regional recurrence or distant metastases as the first site of failure.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Liesbeth Boersma, Prof. | Maastro | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Maastro | Maastricht | Limburg | 6229ET | Netherlands |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D008408 | Mastectomy |
| ID | Term |
|---|---|
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
| OTHER |
| Franciscus Gasthuis | OTHER |
| Haaglanden Medical Centre | OTHER |
| Jeroen Bosch Ziekenhuis | OTHER |
| Maastricht University Medical Center | OTHER |
| Maxima Medical Center | OTHER |
| St. Antonius Hospital | OTHER |
| Laurentius ziekenhuis | UNKNOWN |
| VieCuri Medical Centre | OTHER |
| NKI-AvL | UNKNOWN |
| Ziekenhuis Netwerk Antwerpen (ZNA) | OTHER |
| Aarhus University Hospital | OTHER |
| Sheba Medical Center | OTHER_GOV |
| University of Florence | OTHER |
Not provided
Not provided
Not provided
Anaysis to assess whether treatment-related factors (e.g., PMRT with or without bolus, radiation volumes, doses) influence the site of recurrence and spatial location. |
| Up to 15 years after mastectomy |
| D017437 |
| Skin and Connective Tissue Diseases |